{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:22:07Z","timestamp":1777609327189,"version":"3.51.4"},"reference-count":17,"publisher":"Tsinghua University Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.26599\/1671-5411.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:12:58Z","timestamp":1683529978000},"page":"293-308","source":"Crossref","is-referenced-by-count":9,"title":["Safety of butylphthalide and edaravone in patients with ischemic stroke: a multicenter real-world study"],"prefix":"10.26599","volume":"20","author":[{"given":"Shu-Xian","family":"LYU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Fang","family":"QIAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Fei","family":"FENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Wu","family":"SHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Bo","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Tao","family":"LYU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Fei","family":"JIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yuan","family":"TAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Xuan","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"ZHONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Qun","family":"SU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"HU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Yan","family":"CUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11138","reference":[{"key":"ref1","first-page":"e139","volume":"141","author":"EJ Benjamin","year":"2020","unstructured":"EJ Benjamin. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. 2020, 141: e139-e596.","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1474-4422(18)30500-3","volume":"18","author":"M Liu","year":"2019","unstructured":"M Liu. Stroke in China: advances and challenges in epidemiology, prevention, and management. 2019, 18: 394-405.","journal-title":"Lancet Neurol"},{"key":"ref3","first-page":"666","volume":"51","author":"B Wu","year":"2018","unstructured":"B Wu. [Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018]. 2018, 51: 666-682.","journal-title":"Chin J Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1871527317666180612125843","volume":"17","author":"L Huang","year":"2018","unstructured":"L Huang. Dl-3-n-butylphthalide (NBP): a promising therapeutic agent for ischemic stroke. 2018, 17: 338-347.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3164\/jcbn.17-62","volume":"62","author":"S Yuki","year":"2018","unstructured":"S Yuki. How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?. 2018, 62: 20-38.","journal-title":"J Clin Biochem Nutr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/00207454.2014.959121","volume":"125","author":"X Song","year":"2015","unstructured":"X Song. Edaravone\u2019s free radical scavenging mechanisms of neuroprotection against cerebral ischemia: review of the literature. 2015, 125: 555-565.","journal-title":"Int J Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/jcpt.13392","volume":"46","author":"L Lin","year":"2021","unstructured":"L Lin. Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: a meta-analysis of randomized controlled trials. 2021, 46: 907-917.","journal-title":"J Clin Pharm Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","volume":"25","author":"Society of Pharmacoepidemiology International","year":"2016","unstructured":"Society of Pharmacoepidemiology International. Guidelines for good pharmacoepidemiology practice (GPP). 2016, 25: 2-10.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"Medical Association World","year":"2013","unstructured":"Medical Association World. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. 2013, 310: 2191-2194.","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"122915","DOI":"10.1016\/j.jchromb.2021.122915","volume":"1181","author":"Y He","year":"2021","unstructured":"Y He. Absorption, distribution, metabolism, and excretion of [C]NBP (3-n-butylphthalide) in rats. 2021, 1181: 122915.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.111.043356","volume":"40","author":"Y Peng","year":"2012","unstructured":"Y Peng. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. 2012, 40: 734-741.","journal-title":"Drug Metab Dispos"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/sim.4780071110","volume":"7","author":"J Naus","year":"1988","unstructured":"J Naus. Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. 1988, 7: 1171-1175.","journal-title":"Stat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","volume":"7","author":"J Hallas","year":"1996","unstructured":"J Hallas. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. 1996, 7: 478-484.","journal-title":"Epidemiology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.1736","volume":"18","author":"J Hallas","year":"2009","unstructured":"J Hallas. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. 2009, 18: 483-491.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40264-015-0391-8","volume":"39","author":"LK Ellett","year":"2016","unstructured":"LK Ellett. Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database. 2016, 39: 347-354.","journal-title":"Drug Saf"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/pds.3440","volume":"22","author":"U Bergman","year":"2013","unstructured":"U Bergman. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. 2013, 22: 915-924.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1080\/14740338.2016.1238071","volume":"15","author":"NK Choi","year":"2016","unstructured":"NK Choi. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis. 2016, 15: 1589-1595.","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T07:13:13Z","timestamp":1683529993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2023.04.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2023.04.002","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}